Fagron increases share capital through exercise subscription rights

Group 1 - Fagron has issued 85,000 new shares as a result of the exercise of subscription rights on June 6, 2025 [1] - The total share capital of Fagron currently amounts to €504,303,905.59, with a total of 73,313,904 shares with voting rights [2] - There are 1,465,833 rights to subscribe to not yet issued shares with voting rights [2] Group 2 - Fagron is a leading global company in pharmaceutical compounding, providing personalized medicine to various healthcare facilities in 35 countries [3] - The company is registered in Nazareth and listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR' [4] - Fagron's operational activities are managed by its Dutch subsidiary, Fagron BV, headquartered in Rotterdam [4]